Subscribe To
Nestle divests peanut allergy business palforzia
Nestle has divested its peanut allergy treatment business Palforzia, the Swiss food company said on Mon...
September 4, 2023, 1:25 am
Why shares of dbv technologies jumped thursday
The company's peanut allergy treatment patch could have a wide impact. DBV Technologies currently has n...
May 11, 2023, 3:31 pm
Allergy therapeutics peanut vaccine candidate negotiates its early clinical hurdle
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) has announced a significant milestone in its innovative peanut ...
April 19, 2023, 2:41 am
Allergy therapeutics doses first patients with peanut allergy vaccine
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF), the commercial-stage biotech company, has started administering its groundbreaking short-course ...
March 27, 2023, 2:36 am
Allergy therapeutics doses first patient in 'pivotal' hay fever trial
Allergy Therapeutics said it had dosed its first patient in a phase III trial for a new grass pollen vaccine, while screening is underway for a safety...
December 8, 2022, 2:39 am
Allergy therapeutics to present 18 posters at eaaci conference
Allergy Therapeutics said will present 18 posters and host two symposia at the European Academy of Allergy and Clinical Immunology (EAACI) 2022 this m...
July 1, 2022, 3:03 am
Dbv technologies shares jump on positive data from peanut allergy trial in toddlers
DBV Technologies SA's (NASDAQ: DBVT) pivotal Phase 3 EPITOPE trial of Viaskin Peanut 250 µg for peanut-allergic toddlers ages 1 to 3 years met its ...
June 8, 2022, 7:24 am
Allergy therapeutics primed for a pivotal year
Allergy Therapeutics PLC (AIM:AGY) said it was primed for a pivotal year as it prepared to get two key clinical trials underway. A ground-breaking pha...
March 3, 2022, 3:58 am
Allergy therapeutics primed for a pivotal year
Allergy Therapeutics PLC (AIM:AGY) said it was primed for a pivotal year as it prepared to get two key clinical trials underway. A ground-breaking pha...
March 3, 2022, 3:58 am
Allergy therapeutics primed for a pivotal year
Allergy Therapeutics PLC (AIM:AGY) said it was primed for a pivotal year as it prepared to get two key clinical trials underway. A ground-breaking pha...
March 3, 2022, 3:58 am
Allergy therapeutics shares up 9% after it gets the fda green light to begin phase i peanut allergy trial
Shares in Allergy Therapeutics PLC (AIM:AGY) rose 9% in early trade after the group said the US regulator had given the green light for trials to begi...
January 26, 2022, 3:21 am
Allergy therapeutics shares up 9% after it gets the fda green light to begin phase i peanut allergy trial
Shares in Allergy Therapeutics PLC (AIM:AGY) rose 9% in early trade after the group said the US regulator had given the green light for trials to begi...
January 26, 2022, 3:21 am
Allergy therapeutics shares up 9% after it gets the fda green light to begin phase i peanut allergy trial
Shares in Allergy Therapeutics PLC (AIM:AGY) rose 9% in early trade after the group said the US regulator had given the green light for trials to begi...
January 26, 2022, 3:21 am